MeiraGTx
ScaleupBiotech & Life Sciences
Clinical-stage developer of AAV gene therapies (eye disease, Parkinson's, salivary gland) with gene-regulation/riboswitch technology and in-house GMP viral vector manufacturing; listed on Nasdaq (MGTX).
Locations
London, United Kingdom
34-38 Provost Street, London, Greater London, N1 7NG, United Kingdom
View on mapNew York, United States (Headquarters)
655 Third Avenue, Suite 1115, New York, NY, 10017, United States
View on map